Seroprevalence of SARS-CoV-2 and Hepatitis B Virus Coinfections among Ethiopians with Acute Leukemia

被引:1
作者
Alemu, Jemal [1 ,2 ,3 ]
Gumi, Balako [3 ]
Tsegaye, Aster [1 ]
Rahimeto, Ziyada [2 ]
Fentahun, Dessalegn [2 ]
Ibrahim, Fozia [2 ]
Abubeker, Abdulaziz [4 ]
Gebremedhin, Amha [4 ]
Gelanew, Tesfaye [2 ]
Howe, Rawleigh [2 ]
机构
[1] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, POB 1176, Addis Ababa, Ethiopia
[2] Armauer Hansen Res Inst, POB 1005, Addis Ababa, Ethiopia
[3] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, POB 1176, Addis Ababa, Ethiopia
[4] Addis Ababa Univ, Coll Hlth Sci, Dept Internal Med, POB 1176, Addis Ababa, Ethiopia
关键词
SARS-CoV-2; blood-borne viruses; acute leukemia; HBV; Ethiopia; INFECTION; COVID-19; CELL;
D O I
10.3390/cancers16081606
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SARS-CoV-2 and blood-borne viral coinfections are well reported. Nevertheless, little is known regarding the seroprevalence of SARS-CoV-2 and coinfection with blood-borne viruses in hematologic malignancy patients in Ethiopia. We aimed to assess the seroprevalence of SARS-CoV-2 and associated infections with hepatitis B and other viruses among adolescent and adult acute leukemia patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. A cross-sectional study was conducted from July 2020 to June 2021. Blood samples were tested for the presence of anti-SARS-CoV-2, HBV, HCV, and HIV with ELISA kits and occult hepatitis B infection with a real-time polymerase chain reaction assay. Out of a total 110 cases, the SARS-CoV-2 seroprevalence was 35.5%. The prevalence showed a significant increment from July 2020 to the end of June 2021 (p = 0.015). In 22.7% and 2.7% of leukemia cases, HBV and HIV, respectively, were detected. No HCV was identified. The rate of SARS-CoV-2 coinfection with HBV and HIV was 28% (11/39) and 2.6% (1/39), respectively; however, there was no statistically significant association between SARS-CoV-2 seropositivity with HBV and HIV (p > 0.05). There is a need for viral screening in leukemia cases to monitor infections and inform management.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] SARS-CoV-2 Seroprevalence at an Urban Hospital in Haiti
    Price, Robert
    Cho, Jeffrey
    Nelson, Scott
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [32] SARS-CoV-2 Exposure and Seroprevalence of SARS-CoV-2 Antibodies among Medical Students in the First Phase of the Pandemic 2020-2021
    Landmesser, Patricia
    Weissbrich, Benedikt
    Peter-Kern, Martina
    Krone, Manuel
    Liese, Johannes
    Streng, Andrea
    GESUNDHEITSWESEN, 2024, 86 (04) : 311 - 314
  • [33] SARS-CoV-2 Antibody Seroprevalence in Jakarta, Indonesia
    Ariawan, Iwan
    Jusril, Hafizah
    Farid, Muhammad N.
    Riono, Pandu
    Wahyuningsih, Wiji
    Widyastuti, Widyastuti
    Handayani, Dwi Oktavia T. L.
    Wahyuningsih, Endang Sri
    Daulay, Rebekka
    Henderiawati, Retno
    Malik, Safarina G.
    Noviyanti, Rintis
    Trianty, Leily
    Fadila, Nadia
    Myint, Khin Saw Aye
    Yudhaputri, Frilasita A.
    Venkateswaran, Neeraja
    Venkateswaran, Kodumudi
    Udhayakumar, Venkatachalam
    Hawley, William A.
    Morgan, Juliette
    Pronyk, Paul M.
    KESMAS-NATIONAL PUBLIC HEALTH JOURNAL, 2022, 17 (03): : 169 - 174
  • [34] SARS-CoV-2 seroprevalence in the Vatican City State
    Ralli, Massimo
    Arcangeli, Andrea
    Soave, Paolo Maurizio
    Voglino, Maria Cristina
    De-Giorgio, Fabio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 86 : 98 - 99
  • [35] A seroprevalence study of SARS-CoV-2 and seasonal coronaviruses after the first SARS-CoV-2 circulation in New Caledonia, Pacific region
    Huet, Karl
    White, Michael
    Griffon, Anne-Fleur
    Bloch, Emma
    Magnat, Elodie
    Baudemont, Gaelle
    Inizan, Catherine
    Mena, Pascale Domingue
    Dupont-Rouzeyrol, Myrielle
    IJID REGIONS, 2024, 11
  • [36] Update on SARS-CoV-2 seroprevalence: regional and worldwide
    Rostami, Ali
    Sepidarkish, Mahdi
    Fazlzadeh, Aylar
    Mokdad, Ali H.
    Sattarnezhad, Aida
    Esfandyari, Sahar
    Riahi, Seyed Mohammad
    Mollalo, Abolfazl
    Dooki, Mohammadreza Esmaeili
    Bayani, Masomeh
    Nazemipour, Maryam
    Mansournia, Mohammad Ali
    Hotez, Peter J.
    Gasser, Robin B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1762 - 1771
  • [37] Seroprevalence of SARS-CoV-2 in Mazandaran province, Iran
    Mousavi, Seyed
    Rouhanizadeh, Hamed
    Saeedi, Majid
    Moosazadeh, Mahmood
    Ajami, Abolqasem
    Fendereski, Afsaneh
    Yazdani-Charati, Jamshid
    Soleimani, Seyed
    Ahangar, Nader
    Seyedpour, Seyed
    Bandalizaeh, Zahra
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2021, 14 (01) : 10 - 16
  • [38] Seroprevalence of SARS-CoV-2 virus antibodies in schoolchildren in the city of Sao Paulo, 2020
    Kamioka, Gabriela Akemi
    Madalosso, Geraldine
    de Albuquerque, Jose Olimpio Moura
    Costa, Selma Anequini
    Ferreira, Paula Bisordi
    Sato, Ana Paula Sayuri
    Glasser, Paula Regina
    Pino, Francisco Alberto
    Burihan, Patricia Carla Piragibe Ramos
    de Carvalho, Ana Carolina Aguiar
    Kataoka, Ana Paula Arruda Geraldes
    Savani, Elisa San Martin Mouriz
    Bessa, Thirsa Alvares Franco
    de Aguiar, Breno Souza
    Failla, Marcelo Antunes
    dos Santos, Edson Aparecido
    Brito, Edjane Maria Torreao
    dos Santos, Maria Cristina Honorio
    Caldeira, Luiz Artur Vieira
    Silva, Solange Maria Saboia e
    Zamarco, Luiz Carlos
    Fonseca, Sandra Maria Sabino
    de Cerqueira Lima, Marcia Maria
    Marques, Ivanilda Argenau
    de Marco Franca Mauro, Athene Maria
    de MasiI, Eduardo
    REVISTA DE SAUDE PUBLICA, 2023, 57
  • [39] Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre
    Ziemssen, Focke
    Feng, You-Shan
    Schnichels, Sven
    Bayyoud, Tarek
    Ueffing, Marius
    Bartz-Schmidt, Karl Ulrich
    Martus, Peter
    Peter, Andreas
    BMJ OPEN OPHTHALMOLOGY, 2021, 6 (01):
  • [40] Seroprevalence of SARS-CoV-2 in pediatric hematology-oncology patients
    Phan, Vivian
    Richards, Tiana
    Kang, Keehyo
    Sheridan, Michael
    Levorson, Rebecca
    Defilippi, Christopher
    Yang, Elizabeth
    PEDIATRIC BLOOD & CANCER, 2024, 71 (10)